ZA971716B - 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease - Google Patents

1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease

Info

Publication number
ZA971716B
ZA971716B ZA971716A ZA971716A ZA971716B ZA 971716 B ZA971716 B ZA 971716B ZA 971716 A ZA971716 A ZA 971716A ZA 971716 A ZA971716 A ZA 971716A ZA 971716 B ZA971716 B ZA 971716B
Authority
ZA
South Africa
Prior art keywords
triphenylbut
disease
treating alzheimer
ene derivatives
ene
Prior art date
Application number
ZA971716A
Other languages
English (en)
Inventor
David B Maclean
David D Thompson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA971716B publication Critical patent/ZA971716B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA971716A 1996-02-28 1997-02-27 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease ZA971716B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2520196P 1996-02-28 1996-02-28

Publications (1)

Publication Number Publication Date
ZA971716B true ZA971716B (en) 1998-08-27

Family

ID=21824634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA971716A ZA971716B (en) 1996-02-28 1997-02-27 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease

Country Status (9)

Country Link
US (1) US5719191A (xx)
EP (1) EP0792638A1 (xx)
JP (1) JPH09315961A (xx)
KR (1) KR970061248A (xx)
CN (1) CN1165650A (xx)
AU (1) AU1496597A (xx)
CA (1) CA2198561A1 (xx)
IL (1) IL120269A0 (xx)
ZA (1) ZA971716B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4311870C2 (de) * 1993-04-10 1998-07-30 Altramed Holdings Ltd Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen
WO1998046588A2 (en) * 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
DE19821723C2 (de) * 1998-05-14 2000-07-06 Disetronic Licensing Ag Katheterkopf für subkutane Verabreichung eines Wirkstoffs
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
JP2002518329A (ja) 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー アセチルコリンレベルを増加させる方法
EP0976404A3 (en) * 1998-07-30 2001-06-27 Pfizer Products Inc. A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal
GB9824207D0 (en) * 1998-11-04 1998-12-30 Zeneca Ltd Neurological disorders
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
JP4988110B2 (ja) * 2000-10-05 2012-08-01 クミアイ化学工業株式会社 均一拡散性粒状農薬製剤およびその散布方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046719C2 (de) * 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US5384332A (en) * 1994-05-11 1995-01-24 Eli Lilly And Company Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US5441986A (en) * 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases

Also Published As

Publication number Publication date
MX9701528A (es) 1998-06-28
EP0792638A1 (en) 1997-09-03
AU1496597A (en) 1997-09-04
JPH09315961A (ja) 1997-12-09
IL120269A0 (en) 1997-06-10
CA2198561A1 (en) 1997-08-28
KR970061248A (ko) 1997-09-12
CN1165650A (zh) 1997-11-26
US5719191A (en) 1998-02-17

Similar Documents

Publication Publication Date Title
EP0951293A4 (en) METHOD FOR TREATING ALZHEIMER DISEASE
EP1043991A4 (en) TREATMENT OF ALZHEIMER DISEASE
PL332040A1 (en) Substitution 6,5-heterobicyclic derivatives
PL331988A1 (en) Substitution 6,6-heterobicyclic derivatives
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
AU2001233299A1 (en) Methods for treating alzheimer's disease
IL135584A0 (en) Method for treating alzheimer's disease
AU6932000A (en) Tacrine derivatives for treating alzheimer's disease
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
ZA971716B (en) 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
GB0011410D0 (en) Therapeutic combination for treating Alzheimer's disease
GB0011408D0 (en) Therapeutic combination for treating Alzheimer's Disease
AU5495398A (en) Idebenone containing combination agent for treating alzheimer's disease
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
HUP9802105A3 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
SG50796A1 (en) Process for preparing 1,5-benzothiazepine derivative
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
GB9814045D0 (en) Alzheimer's disease
GB2302871B (en) Process for preparing 1,1-dioxo-cephem-4-ketones
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
ZA974928B (en) Process for the preparation of organic salts of N'N-Diacetylcystine.
ZA975076B (en) Process for the preparation of 2,3-pyridinedicarboxamides
IL147099A0 (en) New use for 1,3-propanediol derivatives